CXCL12 and Bloom syndrome: Specifically, inhibition of CXCR4/CXCL12 signaling with anti-CXCL12 antibody reduced recruitment of CD45+ ColI+ CXCR4+ fibrocytes in BLM exposed mice [25] and reduced lung fibrosis [23, 25–27].